Anticancer Fund: Changemakers on a mission

Unique research and cures

We support the high-impact cancer research others overlook to find better treatments for every patient. Our clinical trials prioritise patient survival and quality of life over financial returns. Discover the non-commercial solutions that are changing the future of cancer care.

The focus of Anticancer Fund

Clinical research

We challenge the status quo by funding innovative clinical trials, like repurposing common, affordable medicines for complex cancers. Learn how we are maximizing existing resources to find effective solutions for cancer therapies

https://www.anticancerfund.org/en/clinical-research/our-research-focus

Patient information

Every patient deserves clear answers. Reach out to the physicians and scientists of My Cancer Navigator for free, science-based information about your specific cancer and treatment options.

https://www.mycancernavigator.org/en

Discover our latest news

Hot flush treatment has anti-breast cancer activity, study finds

A drug mimicking the hormone progesterone has anti-cancer activity when used together with conventional anti-oestrogen treatment for women with breast cancer, a trial coordinated by the University of Cambridge has found.

5 January 2026

Breast cancer patients often receive unnecessary new cancer drugs

Not all cancer patients benefit from new drugs. To study which patients really do, doctors and researchers need access to the clinical data and tissue samples that patients provide in clinical studies. An international group of 53 breast cancer experts and patients representatives is therefore calling for better cooperation between academic institutions and the pharmaceutical sector. Their claim has been published in JAMA Oncology.

19 December 2025

Pushing the boundaries of pancreatic cancer treatment

Pancreatic cancer is one of the most aggressive and challenging malignancies, with a prognosis that remains devastatingly poor. We sat down with Prof. Dr. Christelle Bouchart (ULB, Department of Radiation-Oncology at H.U.B. Institut Jules Bordet), the Investigator of the STEREOPAC-trial.

18 December 2025

International collaboration secures over €11 million for rare cancer clinical trials

Two late-phase clinical trials in rare cancers will receive more than €11 million in funding following the second international ATTRACT call, co-funded by Anticancer Fund.

20 November 2025